In addition to its by stander effect, DXd is cell membrane permeable and therefore may enter nearby cells, even those without strong HER2 expression, making it effective in low HER2-expressing cancer cells and overcome tumour heterogeneity. This evidence concerns the gene ERBB2 and neoplasm.